SLU-PP-332 Metabolic Booster (60 x 250mcg)

Description

250mcg per capsule – 60 caps per product

What Is SLU-PP-332?

SLU-PP-332 is a compound being studied for its interaction with estrogen-related receptors (ERRα, ERRβ, and ERRγ) — nuclear receptors involved in mitochondrial activity and cellular energy balance. Its molecular formula, C₁₈H₁₄N₂O₂, reflects its structure as recorded in scientific literature. Though still under early research, it’s gaining interest in wellness and longevity circles for its potential role in supporting energy metabolism.

Suggested Use

Take one capsule daily with water. For consistent results, aim to take at the same time each day.

Disclaimer

This product is not designed to diagnose, treat, or cure any medical condition. It is a nutritional supplement derived from amino acids and is intended for aesthetic or wellness purposes 

• the most advanced product for the reduction of excess weight
• accelerates the metabolic rate and forces the use of fatty acids as an energy source
• puts the body in a state induced by exercise or fasting
• Protects the heart and liver 
• improves endurance and performance by up to 70%
• has no effect on appetite

Here are the key benefits associated with SLU-PP-332 : 

Weight loss: SLU-PP-332 has shown the ability to promote weight loss in experimental studies, mainly in mice. It has been shown to help mice lose a significant percentage of body weight without affecting appetite or food intake

https://www.eurekalert.org/news-releases/1002687

Fat reduction: SLU-PP-332 administration is associated with a significant reduction in body fat mass without a corresponding decrease in overall body weight. This suggests that it may specifically target fat accumulation

https://www.labroots.com/trending/cardiology/26023/unlocking-potential-exercise-pill-err-agonist-slu-pp-332

Preservation of muscle mass: One notable advantage of SLU-PP-332 is its potential to maintain muscle mass during weight loss, which is often a challenge in traditional weight loss efforts

https://bnn.network/breaking-news/health/new-exercise-mimicking-drug-a-potential-game-changer-in-treating-obesity-diabetes-and-muscle-loss/

Exercise mimicry: SLU-PP-332 has been described as an exercise-mimicking drug. It appears to replicate some of the metabolic benefits typically associated with exercise, making it a potential option for people who cannot engage in physical activity or as an adjunct to exercise routines

https://www.technologynetworks.com/drug-discovery/news/exercise-mimicking-drug-helps-mice-lose-weight-and-boost-endurance-379473

Metabolic syndrome mitigation: Studies suggest that SLU-PP-332 may alleviate metabolic syndrome, a group of conditions that increase the risk of heart disease, stroke and type 2 diabetes

https://jpet.aspetjournals.org/content/early/2023/09/22/jpet.123.001733